Asset Publisher

New method divides patients with ulcerative colitis in groups

New method divides patients with ulcerative colitis in groups

Researchers at CMM have found a way of using gene expression conserved across species to divide patients with the inflammatory bowel disease ulcerative colitis into two distinct groups. The researchers hope that the method can also be used to subdivide other autoimmune diseases.

Ulcerative colitis is an inflammatory bowel disease affecting the colon and rectum. It manifests itself differently in patients, and only 50 to 60 per cent respond to the treatment with so-called biological drugs.

There is therefore a need to divide patients into different groups so that new pharmaceutical targets can be identified and treatments tailored accordingly.

“We’ve managed to divide patients with ulcerative colitis into two molecularly distinct groups using a method that we believe can be used for other diseases too,” says the study’s corresponding author Eduardo Villablanca, associate professor at the Department of Medicine, Solna.

Eduardo Villablanca. Photo: Knut och Alice Wallenbergs Stiftelse, Magnus Bergström

 

The study ”Conserved transcriptomic profile between mouse and human colitis allows unsupervised patient stratification” was published in Nature Communications, online 28 juni 2019.

Read the full news story at Karolinska Institutet website.

NEWS

Unexpected effect of MS drug

Unexpected effect of MS drug Karl Carlström and Fredrik Piehl Photo: Stefan Zimmerman   Researchers at CMM have studied the mechanism of action of a drug used to treat...

New findings about how Parkinson's disease develops

New findings about how Parkinson's disease develops A new study by researchers at CMM shows that the protein alpha-synuclein, which accumulates in patients with Parkinson’s disease, occurs...

New method divides patients with ulcerative colitis in groups

New method divides patients with ulcerative colitis in groups Researchers at CMM have found a way of using gene expression conserved across species to divide patients with the inflammatory...

Rheumatoid arthritic pain could be caused by antibodies

Rheumatoid arthritic pain could be caused by antibodies In a recently published study, researchers at CMM has shown that antibodies that exist in the joints before the onset of rheumatoid...

Financial support from The Swedish Childhood Cancer Fund to Ann Nordgren for her research position

Financial support from The Swedish Childhood Cancer Fund to Ann Nordgren for her research position Research positions are awarded once a year by the Swedish Childhood Cancer Fund. In 2019,...

Rare disease gives new insight into regulatory T-cell function

Rare disease gives new insight into regulatory T-cell function An international study led by researchers at CMM provides new insights into the regulatory T cells’ role in protecting against...

Antibodies stabilize plaque in arteries

Antibodies stabilize plaque in arteries A recent study, led by researchers at CMM, shows that type IgG antibodies play an unexpected role in atherosclerosis. The researchers hope that...

Prestigious grant for research on autoimmunity

Prestigious grant for research on autoimmunity Professor Olle Kämpe is one of five appointed Wallenberg Clinical Scholars in 2019. He will receive SEK 15 million to study why the immune...

Molecular puzzle reveals unknown stages of fetal development

Molecular puzzle reveals unknown stages of fetal development By applying gene analysis to individual cells from early mouse embryos, CMM researcher Qiaolin Deng and her team have discovered...

New skeletal disease found and explained by CMM researchers

New skeletal disease found and explained by CMM researchers Researchers from the group Rare Diseases have discovered a new and rare skeletal disease. In a study published in the journal...